OpenVSafe by OpenVAERS
Search V-safe

BAB-59240-51439

1 vaccination 8 coded responses 16 check-ins 7 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
495 / MI
Registered
2022-06-24
Relationship
Child or adolescent in my care
Guardian
FNG-89770-12660
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-24
    Registered in v-safe
  2. 2022-06-24
    Dose 1 — Moderna
  3. 2022-06-24
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-25
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-06-26
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Insomnia — Feeling: Good
    Free text: Insomnia
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-06-27
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Rhinorrhoea — Feeling: Poor · Fever · Sleepiness, Irritability/crying · Be unable to do your normal daily activities
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness · Be unable to work or attend school
    Under 3 check-in
  8. 2022-06-29
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Nausea — Feeling: Fair · Fever · Irritability/crying
    Free text: Nausea
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-01
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · Fever · None
    Under 3 check-in
  11. 2022-07-08
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-07-15
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-07-22
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-07-29
    Survey response — day 35, dose 1, under 3
    MedDRA: Cough, Lacrimation increased, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Runny nose, watery eyes, cough
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-08-05
    Survey response — day 42, dose 1, under 3
    MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Cough, congestion, runny nose
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-09-23
    Survey response — 3 months, dose 1, under 3
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-12-23
    Survey response — 6 months, dose 1, under 3
    MedDRA: Nasopharyngitis, Respiratory syncytial virus infection, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: RSV diagnosis. A few weeks later a runny nose and standard cold.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-12-23
    Report sent to call center — 6 months, dose 1, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  19. 2022-12-27
  20. 2023-06-25
    Survey response — 12 months, dose 1, under 3
    MedDRA: Cough, Intussusception, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-06-24Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-26

Systemic reaction (other): Insomnia

2022-06-27

Systemic reaction (other): Runny nose

2022-06-29

Systemic reaction (other): Nausea

Release 12 (Under 3) — day 35, dose 1, under 3

2022-07-29

Symptoms: Runny nose, watery eyes, cough

Release 12 (Under 3) — day 42, dose 1, under 3

2022-08-05

Symptoms: Cough, congestion, runny nose

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-09-23

Symptoms: Runny nose

Release 12 (Under 3) — 6 months, dose 1, under 3

2022-12-23

Symptoms: RSV diagnosis. A few weeks later a runny nose and standard cold.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDIntussusception · · ✓
SDLacrimation increased · · ✓
SDNasopharyngitis · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SROInsomnia · · ✓
SRONausea · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release